11:09 AM EDT, 06/11/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts rose late Thursday morning with the S&P Europe Select ADR Index climbing 1.7% to 1,874.97.

From continental Europe, the gainers were led by biopharmaceutical company argenx (ARGX) and semiconductor company Sequans Communications ( SQNS ) , which rose 2.7% and 2.6%, respectively. They were followed by biotech firm BioNTech (BNTX) and telecommunications company Nokia ( NOK ) , which were up 2.5% and 1.6%, respectively.

The decliners from continental Europe were led by software firm SAP (SAP) and internet ad firm Criteo ( CRTO ) , which dropped 4.1% and 0.9%, respectively. They were followed by biotech firm Evaxion ( EVAX ) and consumer goods company Unilever ( UL ) , which were off 0.4% and 0.1%, respectively.

The gainers from the UK were led by pharmaceutical company Silence Therapeutics ( SLN ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which climbed 8.8% and 4%, respectively. They were followed by lender HSBC ( HSBC ) and biotech firm Autolus Therapeutics ( AUTL ) , which advanced 2.8% and 2.7%, respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) and software company Endava ( DAVA ) , which fell 4.6% and 1.1%, respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group ( MREO ) and NuCana ( NCNA ) , which lost 0.9% and 0.8%, respectively.